BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc.
Kivu Bioscience Inc.
Achieve Life Sciences
BioNTech SE
BeOne Medicines
BicycleTx Limited
MOMA Therapeutics
Astellas Pharma Inc
Astellas Pharma Inc
Edwards Lifesciences
Ascendis Pharma A/S
Hoffmann-La Roche
Eli Lilly and Company
Eli Lilly and Company
7 Hills Pharma, LLC
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Merck Sharp & Dohme LLC
ALX Oncology Inc.
AstraZeneca
Plexium, Inc.
Crescent Biopharma, Inc.
Beijing Biotech
Eilean Therapeutics
Parabilis Medicines, Inc.
AVEO Pharmaceuticals, Inc.
Bristol-Myers Squibb
Deciphera Pharmaceuticals, LLC
Revolution Medicines, Inc.
Pfizer
Pfizer
Pfizer
Eikon Therapeutics
USWM, LLC (dba US WorldMeds)
BriaCell Therapeutics Corporation
ARTBIO Inc.
Pfizer
AstraZeneca
AstraZeneca
Coherus Oncology, Inc.
Suzhou Abogen Biosciences Co., Ltd.
Beijing Biotech
Lumos Pharma
Actuate Therapeutics Inc.
Conjupro Biotherapeutics, Inc.
Modulation Therapeutics, Inc.
ModernaTX, Inc.
Taiho Oncology, Inc.
Alterome Therapeutics, Inc.
Verastem, Inc.
IDEAYA Biosciences